GLP-1 Receptor Activation: Suppresses appetite through hypothalamic pathways Slows gastric emptying Enhances insulin secretion GIP Receptor Activation: Amplifies GLP-1 satiety effects Improves insulin sensitivity May directly affect fat cell metabolism Glucagon Receptor Activation: Increases energy expenditure (metabolic rate) Promotes fat breakdown (lipolysis) May prevent metabolic adaptation The Advantage: Single molecule means simpler manufacturing, potentially easier regulatory approval, and all three pathways activated with every dose
Sometimes, reminding me a little bit of Paul Simon
It didn't just work where it was applied
With peptides, you can get the gains you want while minimizing unnecessary side effects
doi: 10.1016/j.ejmech.2020.113041 191 KumarAPasamVRThakurRKSinghMSinghKShuklaMet al
External resources ClinicalTrials.gov - Retatrutide Phase 2 Study (NCT04881760) ClinicalTrials.gov - Retatrutide Phase 3 Study (NCT06859268) For researchers committed to getting the most from their retatrutide protocols, SeekPeptides offers comprehensive protocol guidance, dosing calculators , and a community of thousands who have navigated these exact starting dose decisions